Science Current Events | Science News | Brightsurf.com
 
Email a Friend Send to a friend
Printer Friendly Print Pediatric oncologists should help with difficult decisions

Pediatric oncologists should help with difficult decisions

December 29, 2005

The oncologist should be the primary decision maker in some pediatric cancer situations, say researchers at Baylor College of Medicine (BCM) in Houston in an article appearing today in the Journal of Clinical Oncology.

"The conventional wisdom is that the patient (or parents) should always make the decision because that is their right and duty. We believe that is too simplistic; parents expect and need help from the clinician with difficult decisions," said Dr. Simon Whitney, assistant professor of family and community medicine at BCM.




Whitney, also an associate faculty member of the Center for Medical Ethics and Health Policy at BCM, says the most important thing for clinicians to understand is that there must be a constant dialogue between patients and clinicians. Patients look to clinicians for authority in decision making yet clinicians should know how to read, listen and explain the information so that parents thoroughly understand the options when they have to make a treatment decision.

Treatment options are complex and decisions must sometimes be made at a moment's notice. When there is one clear best way to treat the patient the physician should inform the parent and child of the one treatment option as if it is the only one, including any risks associated with the treatment.

"And in a sense, there is really no decision for the doctor or the parent if there is one best treatment for the child," said Whitney. "The decision has essentially already been made."

There are different reasons why the clinician, the child or the parent should take the lead role in the decision making and depends on each child's circumstances.

"The role of the decision maker in pediatric oncology cases is determined based on disease-related and treatment-related questions that must be answered," said Dr. Stacey Berg, professor of pediatrics - hematology and oncology section at BCM and pediatric oncologist at Texas Children's Cancer Center. "Whether the disease is curable and how many treatment options are available are very important in determining who should take the lead in decision-making."

When there are two treatment options that have similar risks and benefits to the child, the clinician has the obligation to inform the parent and child of both options, including all risks and benefits of each. It is in this situation that the parents have the option of deciding what is best based on the information they receive from the clinician.

"In this situation the clinician and the family both have a role in the decision-making," said Whitney. "The clinician informs the patient of all options and lets them make the best decision based on their understanding of the information presented to them."

Conveying information in simple and clear language leads to better decision-making. When parents understand they are more likely to have an opinion. Clinicians should also explore what matters to the patient to make it easier to help make the decision.

Baylor College of Medicine



Related Pediatric Oncologist Current Events and Pediatric Oncologist News Articles Pediatric Oncologist Current Events and Pediatric Oncologist News RSS Pediatric Oncologist Current Events and Pediatric Oncologist News RSS
For young boys with cancer, testicular tissue banking may be option to preserve fertility
For parents of children with cancer, the hopeful news is that pediatric survival rates have steadily improved for decades. Among the bad news-treatments that enable survival often cause infertility.

New Chemo Cocktail Blocks Breast Cancer Like a Fence
Think of a protective fence that blocks the neighbor's dog from charging into your backyard. The body, too, has fences -- physical and biochemical barriers that keep cells in their place.

New treatment more than doubles survival for high risk childhood leukemia
Results of a phase two clinical trial published October 5th in the Journal of Clinical Oncology show that adding continuous daily doses of a targeted drug called imatinib mesylate to regular chemotherapy more than doubled three-year survival rates for children with a high risk type of blood cancer called Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL).

Studies find few risks to newborn offspring of parents who are childhood cancer survivors
Whether they can have children is one of the major concerns for adult survivors of childhood and adolescent cancer because fertility can be compromised by cancer treatment.

Some radiation therapy treatments can decrease fertility
In female cancer patients of reproductive age, radiation treatment directly to the ovaries should be avoided because there is a direct relationship between certain types of radiation therapy and fertility problems.

Pediatric Hodgkin's disease survivors face increased breast cancer risk
Women who as children got radiation treatment for Hodgkin's disease are almost 40 times more likely than others to develop breast cancer, according to findings from five institutions, including the University of Florida.

The Hsp90-Antifungal Combo, please: Compromising fungi in the immunocompromised
Even the most drug-resistant fungi can be eradicated in multiple in vitro and in vivo models using a lethal combination of an antifungal agent and inhibition of the heat shock protein Hsp90, according to a new study by Whitehead Institute and University of Toronto researchers.

Scientists close in on method to fight deadly childhood cancer
A multicenter team of researchers, including scientists from the University of Florida, has discovered a way to potentially block the growth of neuroblastoma, a type of cancer responsible for 15 percent of all cancer deaths in children.

Survivors of childhood Hodgkin's lymphoma at higher risk of future health problems
Adults who survived childhood Hodgkin's Lymphoma should be especially vigilant about cancer and cardiovascular screenings, according to researchers from Wake Forest University Baptist Medical Center and colleagues.

Natural mechanism for immune suppression paves way for cancer trials
A natural mechanism pirated by tumors and HIV to evade the immune response is opening the door to better treatment for these conditions, researchers say.
More Pediatric Oncologist Current Events and Pediatric Oncologist News Articles
ABC News UpClose Stewart Goldman

ABC News UpClose Stewart Goldman

When asked about working with oncology patients at Children's Memorial Hospital in Chicago, Dr. Stewart Goldman's honest answer was that it was hard, and sometimes he wasn't sure he wanted to do it for the rest of his life. But for now, the gifts his job gave him far outweighed the sadness that comes from being around children who die. Dr. Goldman answers ABC News' questions about his work and its impact on him and his family.

Correspondent: Jim...

  CANCER, ETHICAL ISSUES RELATED TO DIAGNOSIS AND TREATMENT: An entry from Macmillan Reference USA's Encyclopedia of Bioethics
by Christian M. Simon (Author), Eric D. Kodish (Author)

This digital document is an article from Encyclopedia of Bioethics, brought to you by GaleĀ®, a part of Cengage Learning, a world leader in e-research and educational publishing for libraries, schools and businesses. The length of the article is 5824 words. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser. Contains general essays that historically trace the major religious families and traditions, as well as directory listings that include contact and descriptive information on individual churches, religious bodies, and spiritual groups.

© 2009 BrightSurf.com